Post COVID-19 Dysregulated Breathing Research (REMEDY) Study
We have recently commenced a new clinical research study with Chief Investigator Professor Charlotte Bolton and funded by the NIHR...
top of page
Search
Glenn Hearson
- Jan 18, 2023
Registry of Asthma Patients Initiating DUPIXENT® (RAPID)
We have recently commenced a new observational study to characterize the patients who initiate treatment for asthma with DUPIXENT ® in a...
90
Glenn Hearson
- Sep 8, 2022
The WAYFINDER study: To assess the efficacy and safety of tezepelumab in Adults With Severe Asthma
We have recently commenced a new severe asthma study sponsored by AstraZeneca which is being led at Nottingham University Hospitals by Dr...
100
Glenn Hearson
- Aug 15, 2022
Impact of ELX/TEZ/IVA on Patients With Cystic Fibrosis (TRAJECTORY)
We have recently commenced a new study in conjunction with with Vertex Pharmaceuticals Incorporated and Cardiff and Vale University...
43
Glenn Hearson
- Aug 20, 2021
PRISM: Molecular phenotyping of severe asthma patients to determine response to biologic therapies
We will shortly be commencing this important collaborative asthma research funded by a £2.3 million grant from the Medical Research...
176
Glenn Hearson
- May 20, 2020
ACCORD: Study to Assess Multiple Candidate Agents for the Treatment COVID-19
ACCORD: Study to Assess Multiple Candidate Agents for the Treatment #COVID-19
62
Glenn Hearson
- Sep 6, 2019
British Lung Foundation Early COPD Partnership
British Lung Foundation Early COPD Partnership
82
Glenn Hearson
- Sep 6, 2018
NIHR Nottingham BRC Research; It’s Not JUST Idiopathic Pulmonary FibrosiS Study (INJUSTIS)
New NIHR Nottingham BRC Research; It’s Not JUST Idiopathic Pulmonary FibrosiS Study (INJUSTIS)
214
Copyright Nottingham Respiratory Research Unit 2016
Tel: 0115-8404844
bottom of page